Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
Clinical Laboratory
|
April 5, 2014
Donor lymphocytes may acquire cytolytic specificity to donor's engrafted hematopoietic cells after a hematopoietic stem cell allograft resulting in marrow failure
Haizhou Xing, Yuan Ou, Jing Liu, et al.
Expert Opinion on Biological Therapy
|
March 20, 2024
Bispecific antibodies in immunotherapy for adult acute leukemia: latest updates from the 65th American Society of Hematology 2023 Annual Meeting
Lijie Han, Haizhou Xing, Weijie Cao, et al.
Immunobiology
|
January 10, 2017
A specific immune tolerance toward offspring cells is to exist after the mother lymphocyte infusion
Haizhou Xing, Shiqin Liu, Xue Chen, et al.
Journal of Cellular and Molecular Medicine
|
November 6, 2020
Mesenchymal stroma/stem-like cells of GARP knockdown inhibits cell proliferation and invasion of mouse colon cancer cells (MC38) through exosomes
Haizhou Xing, Chunyan Liang, Xintong Xu, et al.
Cell Cycle (Georgetown, Tex.)
|
March 2, 2018
Bone marrow-derived mesenchymal stem cells promote cell proliferation of multiple myeloma through inhibiting T cell immune responses via PD-1/PD-L1 pathway
Dandan Chen, Ping Tang, Linxiang Liu, et al.
Biomarker Research
|
June 1, 2022
Claudin18.2 is a novel molecular biomarker for tumor-targeted immunotherapy
Weijie Cao, Haizhou Xing, Yingmei Li, et al.
Leukemia & Lymphoma
|
August 22, 2013
Significance of CD71 expression by flow cytometry in diagnosis of acute leukemia
Qian Liu, Mangju Wang, Yang Hu, et al.
Expert Opinion on Biological Therapy
|
May 8, 2024
Bispecific antibodies targeting CD20xCD3 in immunotherapy for adult B-cell lymphoma: insights from the 65th American Society of Hematology 2023 annual meeting
Hao Sun, Haizhou Xing, Lijie Han, et al.
Biomarker Research
|
December 8, 2022
Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives
Hao Sun, Yingmei Li, Peng Zhang, et al.
Cancer Management and Research
|
February 27, 2020
Deficient Regulatory Innate Lymphoid Cells and Differential Expression of miRNAs in Acute Myeloid Leukemia Quantified by Next Generation Sequence
Jifeng Yu, Yingmei Li, Yue Pan, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
Clinical Laboratory
|
April 5, 2014
Donor lymphocytes may acquire cytolytic specificity to donor's engrafted hematopoietic cells after a hematopoietic stem cell allograft resulting in marrow failure
Haizhou Xing, Yuan Ou, Jing Liu, et al.
Expert Opinion on Biological Therapy
|
March 20, 2024
Bispecific antibodies in immunotherapy for adult acute leukemia: latest updates from the 65th American Society of Hematology 2023 Annual Meeting
Lijie Han, Haizhou Xing, Weijie Cao, et al.
Immunobiology
|
January 10, 2017
A specific immune tolerance toward offspring cells is to exist after the mother lymphocyte infusion
Haizhou Xing, Shiqin Liu, Xue Chen, et al.
Journal of Cellular and Molecular Medicine
|
November 6, 2020
Mesenchymal stroma/stem-like cells of GARP knockdown inhibits cell proliferation and invasion of mouse colon cancer cells (MC38) through exosomes
Haizhou Xing, Chunyan Liang, Xintong Xu, et al.
Cell Cycle (Georgetown, Tex.)
|
March 2, 2018
Bone marrow-derived mesenchymal stem cells promote cell proliferation of multiple myeloma through inhibiting T cell immune responses via PD-1/PD-L1 pathway
Dandan Chen, Ping Tang, Linxiang Liu, et al.
Biomarker Research
|
June 1, 2022
Claudin18.2 is a novel molecular biomarker for tumor-targeted immunotherapy
Weijie Cao, Haizhou Xing, Yingmei Li, et al.
Leukemia & Lymphoma
|
August 22, 2013
Significance of CD71 expression by flow cytometry in diagnosis of acute leukemia
Qian Liu, Mangju Wang, Yang Hu, et al.
Expert Opinion on Biological Therapy
|
May 8, 2024
Bispecific antibodies targeting CD20xCD3 in immunotherapy for adult B-cell lymphoma: insights from the 65th American Society of Hematology 2023 annual meeting
Hao Sun, Haizhou Xing, Lijie Han, et al.
Biomarker Research
|
December 8, 2022
Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives
Hao Sun, Yingmei Li, Peng Zhang, et al.
Cancer Management and Research
|
February 27, 2020
Deficient Regulatory Innate Lymphoid Cells and Differential Expression of miRNAs in Acute Myeloid Leukemia Quantified by Next Generation Sequence
Jifeng Yu, Yingmei Li, Yue Pan, et al.
Page
of 3